BG
AMED

Bellevue Group’s Amedisys AMED Stock Holding History

Bellevue Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-106,387
Closed -$9.94M – 163
2023
Q3 		$9.94M Sell
106,387
-127,931
-55% -$11.8M 0.16% 91
2023
Q2 		$21.4M Sell
234,318
-308,298
-57% -$25.3M 0.31% 75
2023
Q1 		$39.9M Sell
542,616
-70,896
-12% -$6.13M 0.58% 54
2022
Q4 		$51.3M Buy
613,512
+14,578
+2% +$1.31M 0.68% 47
2022
Q3 		$58M Buy
598,934
+13,780
+2% +$1.64M 0.83% 40
2022
Q2 		$61.5M Buy
585,154
+9,023
+2% +$1.15M 0.87% 39
2022
Q1 		$99.3M Buy
576,131
+86,119
+18% +$12.9M 1.15% 30
2021
Q4 		$79.3M Buy
490,012
+187,214
+62% +$30.1M 0.82% 39
2021
Q3 		$45.1M Buy
302,798
+242,311
+401% +$50.4M 0.46% 69
2021
Q2 		$14.8M Hold
60,487
– – 0.14% 116
2021
Q1 		$16M Sell
60,487
-10,703
-15% -$3.02M 0.17% 108
2020
Q4 		$20.9M Buy
71,190
+9,339
+15% +$2.39M 0.24% 98
2020
Q3 		$14.6M Buy
61,851
+708
+1% +$161K 0.2% 98
2020
Q2 		$12.1M Hold
61,143
– – 0.17% 98
2020
Q1 		$11.2M Buy
61,143
+7,778
+15% +$1.38M 0.22% 78
2019
Q4 		$8.91M Sell
53,365
-122,293
-70% -$18.2M 0.14% 98
2019
Q3 		$23M Buy
175,658
+1,348
+0.8% +$175K 0.43% 53
2019
Q2 		$21.2M Buy
174,310
+140,654
+418% +$16.7M 0.36% 56
2019
Q1 		$4.15M Buy
33,656
+8,452
+34% +$1.06M 0.23% 85
2018
Q4 		$2.95M Hold
25,204
– – 0.19% 90
2018
Q3 		$3.15M Buy
+25,204
New +$2.78M 0.2% 92

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bellevue Group's AMED Position: Q4 2023 in Review

Bellevue Group sold out of Amedisys (AMED) in Q4 2023, closing a stake of 106,387 shares — an estimated $9.94M sold.

Bellevue Group first reported a position in AMED in Q3 2018 and held it in 21 quarters. The position peaked at $99.3M in Q1 2022. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

  • Bellevue Group reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
  • Bellevue Group sold 106,387 Amedisys shares in Q4 2023, an estimated $9.94M.
  • Bellevue Group first reported a position in Amedisys in Q3 2018 and held it in 21 quarters.
  • Bellevue Group's Amedisys position peaked at $99.3M in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Bellevue Group's 13F filing for Q4 2023, filed 14 Feb 2024.